• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION SEPRAFILM; BARRIER, ABSORBABLE, ADHESION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION SEPRAFILM; BARRIER, ABSORBABLE, ADHESION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Post Operative Wound Infection (2446)
Event Type  Injury  
Manufacturer Narrative
(b)(6).Literature article: lee, k.And huang, j., ¿short-term post-operative outcomes between 4% icodextrin solution and hyaluronic acid-carboxylmethyl cellulose membrane during emergency caesarean section¿.Journal of clinical medicine (2019) 8, 1249; doi:10.3390/jcm8081249.The device was not returned, and the lot number is unknown; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
A study was performed in which nine patients experienced post-operative incisional wound infections after undergoing emergency caesarean sections in which seprafilm was used.It was reported the seprafilm was placed over the anterior surface of the uterus, including the incisional site.Skin closure was performed using subcuticular sutures, and a sterile dressing was applied.Treatment for the incisional wound infections was not reported.No further details were provided regarding medical interventions or patient outcomes.No additional information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SEPRAFILM
Type of Device
BARRIER, ABSORBABLE, ADHESION
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
GENZYME CORPORATION
51 and 74-80 new york avenue
framingham MA 01701
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key10567589
MDR Text Key207951193
Report Number1416980-2020-05892
Device Sequence Number1
Product Code MCN
Combination Product (y/n)Y
Reporter Country CodeTW
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/28/2020
Initial Date FDA Received09/22/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-